Skip to main content
logo
CSPC Pharmaceutical Group Limited (FRA:CVGU)
Germany flag Germany · Delayed Price · Currency is EUR
3.340
+0.260 (8.44%)
Last updated: Dec 19, 2025, 8:01 AM CET

Revenue by Geography

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212017 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 2017 - 2020
Mainland China Revenue
21.40B25.11B
Log In
Log In
Log In
Upgrade
Other Asian Regions Revenue
1.20B1.18B
Log In
Log In
Log In
Upgrade
North America Revenue
1.38B853.04M
Log In
Log In
Log In
Upgrade
Americas Revenue
--
Log In
Log In
Log In
Upgrade
Europe Revenue
1.41B1.31B
Log In
Log In
Log In
Upgrade
Other Geographies Revenue
604.24M553.88M
Log In
Log In
Log In
Upgrade
Other Geographies Revenue (Pre-FY2023 Reporting)
--
Log In
Log In
Log In
Upgrade

Revenue

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212017 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 2017 - 2020
Nervous System Revenue
8.16B9.65B
Log In
Log In
Log In
Upgrade
Oncology Revenue
2.77B4.40B
Log In
Log In
Log In
Upgrade
Anti-Infectives Revenue
3.44B4.09B
Log In
Log In
Log In
Upgrade
Cardiovascular Revenue
1.72B2.08B
Log In
Log In
Log In
Upgrade
Respiratory System Revenue
1.02B1.20B
Log In
Log In
Log In
Upgrade
Digestion and Metabolism Revenue
932.10M1.05B
Log In
Log In
Log In
Upgrade
Other Therapeutic Areas Revenue
1.31B1.26B
Log In
Log In
Log In
Upgrade
Total Finished Drugs Revenue
19.34B23.72B
Log In
Log In
Log In
Upgrade
Vitamin C Revenue
2.21B1.99B
Log In
Log In
Log In
Upgrade
Antibiotics Revenue
1.60B1.59B
Log In
Log In
Log In
Upgrade
Total Bulk Products Revenue
3.80B3.58B
Log In
Log In
Log In
Upgrade
Licence Fee Income
1.09B17.83M
Log In
Log In
Log In
Upgrade
Functional Food and Others Revenue
1.76B1.69B
Log In
Log In
Log In
Upgrade

EBIT

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212017 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 2017 - 2020
Finished Drugs Segment Profit
3.73B4.83B
Log In
Log In
Log In
Upgrade
Vitamin C Segment Profit
324.64M211.28M
Log In
Log In
Log In
Upgrade
Antibiotics Segment Profit
258.20M299.18M
Log In
Log In
Log In
Upgrade
Total Bulk Products Segment Profit
582.84M510.45M
Log In
Log In
Log In
Upgrade
Functional Food and Others Segment Profit
339.79M305.29M
Log In
Log In
Log In
Upgrade
Updated Jun 30, 2025. Data Source: Fiscal.ai.